Perfluorohexyloctane

Perfluorohexyloctane
Names
Trade namesMiebo
Other namesNOV03; 1-(perfluorohexyl)octane
IUPAC name
  • 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane
Clinical data
Main usesDry eye disease[1]
Side effectsBlurry vision[1]
WHO AWaReUnlinkedWikibase error: ⧼unlinkedwikibase-error-statements-entity-not-set⧽
Routes of
use		Eye drop[1]
Typical dose1 drop QID[1]
Legal
License data
Legal status
Chemical and physical data
FormulaC14H17F13
Molar mass432.269 g·mol−1
3D model (JSmol)
SMILES
  • CCCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
InChI
  • InChI=1S/C14H17F13/c1-2-3-4-5-6-7-8-9(15,16)10(17,18)11(19,20)12(21,22)13(23,24)14(25,26)27/h2-8H2,1H3
  • Key:WRYIIOKOQSICTB-UHFFFAOYSA-N

Perfluorohexyloctane, sold under the brand name Miebo is a medication used for the treatment of dry eye disease.[1] It is used as an eye drop.[1]

Side effects may include blurry vision.[1] It is a semifluorinated alkane and believed to work by preventing evaporation of tears.[1]

Perfluorohexyloctane was approved for medical use in the United States in 2023.[1] In the United States it costs about 780 USD for a 3 ml bottle as of 2023.[2]

Medical uses

Perfluorohexyloctane is indicated for the treatment of the signs and symptoms of dry eye disease.[1]

Dosage

It is used as one drop four times per day.[1]

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 "Miebo- perfluorohexyloctane solution". DailyMed. 18 May 2023. Archived from the original on 14 August 2023. Retrieved 8 June 2023.
  2. ↑ "Miebo". GoodRx. Retrieved 14 August 2023.
Identifiers:
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.